Panugan, Felipe M.

HRN: 04-40-26  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/12/2022
CEFUROXIME 1.5GM (VIAL)
04/12/2022
04/19/2022
IV
1.5G
Q8
COMPLICATED UTI
04/16/2022
CEFTRIAXONE 1G (VIAL)
04/16/2022
04/23/2022
IV
2g
Q12
Bacterial Meningitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: